Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-11-14

FDA Approved: AMLODIPINE AND VALSARTAN — Supplemental Application (Strides Pharma Science Limited)

View source ↗

Summary

The FDA approved a supplemental application for a Strides Pharma amlodipine/valsartan combination product, authorizing its use for the treatment of hypertension…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMLODIPINE AND VALSARTAN (amlodipine and valsartan)

Snippet

SUPPL AP for AMLODIPINE AND VALSARTAN (AMLODIPINE AND VALSARTAN)